Christophe Bonny has become chief scientific officer at Enterome Bioscience SA which is developing products derived from the human microbiome. He joins the France-based company from Bicycle Therapeutics Ltd where he was also CSO. Prior to this, he was CSO and president at Switzerland-based Xigen SA which is developing peptide drugs against inflammation.
Dr Bonny holds a PhD in molecular biology from the University of Neuchâtel in Switzerland and completed a business and entrepreneurship programme at Babson College in the US. Enterome Bioscience announced the appointment on 3 November 2016.
Copyright 2016 Evernow Publishing Ltd